Evidence map›Paper›PMID 41533801›Full record

ArticleScience advances2026

The genesis of citrated ultrathin hydroxyapatite nanorods.

Yuqi Wang, Su Yan, Xinyu Tan, Ethan Gerhard, Hui Xu, Haiyue Jiang, Jian Yang

Abstract read
In one paragraph

Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuqi WangDepartment of Biomedical Engineering, The Pennsylvania State University, University Park, PA 16802, USA.
Su YanDepartment of Biomedical Engineering, The Pennsylvania State University, University Park, PA 16802, USA.ORCID 0000-0002-4810-7769
Xinyu TanDepartment of Traumatic Surgery, Center for Orthopaedic Surgery, The Third Affiliated Hospital of Southern Medical University, Guangdong 510630, P.R. China.ORCID 0000-0003-4385-7795
Ethan GerhardDepartment of Biomedical Engineering, The Pennsylvania State University, University Park, PA 16802, USA.
Hui XuDepartment of Biomedical Engineering, The Pennsylvania State University, University Park, PA 16802, USA.ORCID 0009-0003-3419-3912
Haiyue JiangPlastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100144, P.R. China.ORCID 0009-0003-5838-4828
Jian YangDepartment of Materials Science and Engineering, School of Engineering, Westlake University, Hangzhou, Zhejiang 310030, P.R. China.ORCID 0000-0003-0695-828X

Funding

Novel nanoparticles to stimulate therapeutic angiogenesis in peripheral arterial diseaseR01HL158204 · NHLBI · UNIVERSITY OF TEXAS ARLINGTON · PI LIU, LI, NGUYEN, KYTAI TRUONG · 2022 to 2025
$2.2M
Photoacoustic and epigenetic nerve scaffold for nerve regenerationR01NS123433 · NINDS · PENNSYLVANIA STATE UNIVERSITY, THE · PI Su Yan · 2022 to 2026
$2.1M
NHLBI NIH HHS R01 HL158204NINDS NIH HHS R01 NS123433
6 · The paper itself

Abstract

Ideal orthopedic biomaterials should replicate both the hierarchical structure and exceptional mechanical strength of natural bone. Traditional polymer-hydroxyapatite composites, typically limited up to 40 wt % hydroxyapatite, offer only modest mechanical improvements. Efforts to enhance strength by using stiffer polymers have largely failed, as increased polymer stiffness does not translate to improved composite mechanics. In contrast, natural bone's load-bearing capability arises from the synergy between citrate, soft collagen, and ultrathin hydroxyapatite nanocrystals (~3 nanometers). Here, we show that elastic poly(octamethylene citrate) enables up to 60 wt % hydroxyapatite incorporation, mimicking the bone's mineral content. Through a top-down "citrification" process and hot pressing, hydroxyapatite microparticles are partially dissolved and recrystallized into superthin (~5 nanometers) nanorods, enhancing organic-inorganic integration and replicating bone's Ca/P ratios and architecture. The resulting composites exhibit compressive strengths exceeding 250 megapascals, unprecedented in polymer-mineral systems, offering a molecular design strategy for next-generation load-bearing orthopedic implants.

Indexed as

Biocompatible MaterialsCitric AcidDurapatiteNanotubesCompressive StrengthMaterials TestingBiocompatible MaterialsCitric AcidDurapatite

Identifiers

PMID41533801
PMCPMC12802829

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.